Diana Sutherland, NP, discusses the promise of CDK4 inhibitors in patients with metastatic breast cancer.
Diana Sutherland, NP
Advertisement
Articles by Diana Sutherland, NP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer
2
GI Cancer Monthly Rewind: Key News and Expert Insights You May Have Missed in September 2026
3
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
4
Five Under 5: Top Oncology Videos for the Week of 10/5/2026
5